Drugs / Xartemis
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02101476 Comparator | May → Aug 2014 | — | Lotus Clinical Research, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xartemis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02101476 ↗ |
| Route | Oral | “Xartemis 15mg/650mg by mouth every 12 hours” NCT02101476 ↗ |